MARAVAI LIFESCIENCES HLDGS-A (MRVI)
US56600D1072 - Common Stock
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
Carl Hull to Retire as Executive Chairman
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
Carl Hull to Retire as Executive Chairman...
Will Insiders Be Tempted To Buy More MRVI At The New 52-Week Low?
Bargain Bin Stocks: MRVI Now 23.7% Cheaper Than Director Deford's Buy
Maravai LifeSciences Announces November 2024 Investor Conference Schedule
Maravai LifeSciences Announces November 2024 Investor Conference Schedule
SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to...
Maravai LifeSciences Holdings Enters Oversold Territory (MRVI)
Maravai LifeSciences (MRVI) Q3 2024 Earnings Call Transcript
MRVI earnings call for the period ending September 30, 2024.
Maravai LifeSciences Reports Third Quarter 2024 Financial Results
Maravai LifeSciences Reports Third Quarter 2024 Financial Results
Announces Agreement to Acquire the DNA and RNA business of Officinae Bio, Advancing Support for Innovative Nucleic Acid R&D SAN DIEGO, Calif., Nov. ...
Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research
MRVI Makes Bullish Cross Above Critical Moving Average
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024
SAN DIEGO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services...
TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA Polymerase
Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes™ Host Cell DNA Quantification Kits
Maravai Lifesciences Shares Soar After Reported Takeover Offer
Maravai Lifesciences Holdings Inc. shares soared after a report that the company received a takeover offer from Repligen Corp.
First Week of October 18th Options Trading For Maravai LifeSciences Holdings (MRVI)
Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule
Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule
SAN DIEGO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to...
Maravai LifeSciences (MRVI) Q2 2024 Earnings Call Transcript
MRVI earnings call for the period ending June 30, 2024.
Maravai LifeSciences Reports Second Quarter 2024 Financial Results
Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation
Maravai LifeSciences Reports Second Quarter 2024 Financial Results
Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation...
Maravai LifeSciences Appoints Trey Martin to Board of Directors
Maravai announces the appointment of CEO Trey Martin to its Board of Directors, highlighting his leadership, commitment to innovation, and industry experience
First Week of March 2025 Options Trading For Maravai LifeSciences Holdings (MRVI)
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024
SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services...
Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report
Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report
- Highlights progress across four priority areas and commitment to environmentally and socially responsible growth. - Conducted first stakeholder...
Bird Flu Vaccine Faces Hurdles Without Better Data, Critics Say
US scientists haven’t gotten a handle on how to effectively track bird flu, three months after a Texas dairy worker was diagnosed with the virus. That’s impeding the ability to create a vaccine to protect against the spread among people.